MedPath
FDA Approval

OXYGEN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 24, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Oxygen(99.5 L in 100 L)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Indiana Oxygen Company Inc

006036776

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Indiana Oxygen Company Inc

Indiana Oxygen Company Inc

Indiana Oxygen Company Inc

006036776

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OXYGEN

Product Details

NDC Product Code
48546-0002
Application Number
NDA205767
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
February 11, 2022
OxygenActive
Code: S88TT14065Class: ACTIBQuantity: 99.5 L in 100 L

OXYGEN

Product Details

NDC Product Code
48546-0006
Application Number
NDA205767
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
February 11, 2022
OxygenActive
Code: S88TT14065Class: ACTIBQuantity: 99 L in 100 L

OXYGEN

Product Details

NDC Product Code
48546-0004
Application Number
NDA205767
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
February 11, 2022
OxygenActive
Code: S88TT14065Class: ACTIBQuantity: 99.6 L in 100 L

OXYGEN

Product Details

NDC Product Code
48546-0001
Application Number
NDA205767
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
February 11, 2022
OxygenActive
Code: S88TT14065Class: ACTIBQuantity: 99 L in 100 L
© Copyright 2025. All Rights Reserved by MedPath